The core claims check out, with a few details worth reading closely. Warhound came out of stealth on Thursday, October 22, 2026, with $200 million in seed funding at a reported $1.2 billion valuation. Backers include Sequoia, 8VC, Corner Ventures and In-Q-Tel, the CIA-backed venture arm (TechCrunch).
The science is the part to read carefully. The company says it plans to biobank cells from proven Belgian Malinois and German Shepherds, clone the best performers, then edit genes for traits such as hereditary health, speed and smell. None of these dogs exist yet. Colossal, Lamm's company, licenses its genetics and cloning technology to Warhound and owns a stake in it. Anduril would supply vests, ear and eye protection and its EagleEye system, but it is not a source of the genetics.
The timelines differ. The post's early-2027 birth date matches the launch statement about a first batch being born early next year, but Benzinga quotes Lamm expecting the first dogs in about two years, and reports that no customers have signed yet (Benzinga).
On the dire wolf: Colossal's earlier dire wolves were gray wolves with edited genes, not revived ancient animals, so the roughly 10,000-year figure describes the extinct species, not a living descendant.
🕒 As of October 2026
